KR20160015718A - Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide - Google Patents
Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide Download PDFInfo
- Publication number
- KR20160015718A KR20160015718A KR1020140098338A KR20140098338A KR20160015718A KR 20160015718 A KR20160015718 A KR 20160015718A KR 1020140098338 A KR1020140098338 A KR 1020140098338A KR 20140098338 A KR20140098338 A KR 20140098338A KR 20160015718 A KR20160015718 A KR 20160015718A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- phytoncide
- composition
- female
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 97
- 239000000284 extract Substances 0.000 title claims abstract description 55
- 244000234609 Portulaca oleracea Species 0.000 title 1
- 235000001855 Portulaca oleracea Nutrition 0.000 title 1
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 238000009472 formulation Methods 0.000 claims abstract description 12
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 11
- 241000202807 Glycyrrhiza Species 0.000 claims abstract description 9
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000003599 detergent Substances 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 230000000845 anti-microbial effect Effects 0.000 claims description 12
- 229940121375 antifungal agent Drugs 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000004203 carnauba wax Substances 0.000 claims description 6
- 235000013869 carnauba wax Nutrition 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 108010076667 Caspases Proteins 0.000 claims description 5
- 102000011727 Caspases Human genes 0.000 claims description 5
- 244000204900 Talipariti tiliaceum Species 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 235000021374 legumes Nutrition 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 240000004307 Citrus medica Species 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 2
- 235000002566 Capsicum Nutrition 0.000 claims description 2
- 235000002789 Panax ginseng Nutrition 0.000 claims description 2
- 239000006002 Pepper Substances 0.000 claims description 2
- 235000016761 Piper aduncum Nutrition 0.000 claims description 2
- 235000017804 Piper guineense Nutrition 0.000 claims description 2
- 244000203593 Piper nigrum Species 0.000 claims description 2
- 235000008184 Piper nigrum Nutrition 0.000 claims description 2
- 239000012871 anti-fungal composition Substances 0.000 claims description 2
- 235000006533 astragalus Nutrition 0.000 claims description 2
- 229930182494 ginsenoside Natural products 0.000 claims description 2
- 229940116257 pepper extract Drugs 0.000 claims description 2
- 235000020737 peppermint extract Nutrition 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims 2
- 235000001050 hortel pimenta Nutrition 0.000 claims 2
- 229940030961 sorghum extract Drugs 0.000 claims 2
- 240000004371 Panax ginseng Species 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 206010046914 Vaginal infection Diseases 0.000 description 16
- 201000008100 Vaginitis Diseases 0.000 description 15
- 241000222122 Candida albicans Species 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 229940095731 candida albicans Drugs 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- 230000002265 prevention Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 241000207201 Gardnerella vaginalis Species 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- -1 phenol compound Chemical class 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000037009 Vaginitis bacterial Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229960004130 itraconazole Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000219312 Chenopodium Species 0.000 description 2
- 244000180278 Copernicia prunifera Species 0.000 description 2
- 235000010919 Copernicia prunifera Nutrition 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 208000004746 Atrophic Vaginitis Diseases 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102000003952 Caspase 3 Human genes 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102100035904 Caspase-1 Human genes 0.000 description 1
- 108090000426 Caspase-1 Proteins 0.000 description 1
- 241000723436 Chamaecyparis obtusa Species 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000028523 Hereditary Complement Deficiency disease Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000593922 Quercus acutissima Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 240000003803 Torilis japonica Species 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 쇠비름 추출물 및 피톤치드를 함유하는 여성 청결제 조성물에 관한 것으로서, 보다 상세하게는 쇠비름 추출물 및 피톤치드를 유효성분으로 함유하는 천연 여성 청결제 조성물 및 이의 제조방법에 관한 것이다. 본 발명의 조성물은 자연으로부터 추출된 천연 추출물로서 인체의 적용에 있어서 부작용 및 독성이 없어 부담없이 적용가능하고, 항균 및 항진균 효과가 우수하며, 또한, 여러 제형으로 제조될 수 있는 제형 우수성이 뛰어나 환자의 취향과 편리성에 따른 제품화가 가능하다.The present invention relates to a female cleanser composition containing a glycyrrhiza extract and phytoncide, and more particularly, to a natural female cleanser composition containing a glycyrrhiza extract and phytoncide as an active ingredient and a method for producing the same. The composition of the present invention is a natural extract extracted from nature and can be applied without any side effects and toxicity in the application of the human body, has excellent antibacterial and antifungal effects, and is excellent in formulation excellence that can be prepared in various formulations, It is possible to commercialize it according to taste and convenience of the user.
Description
본 발명은 천연 여성 청결제 및 이의 제조방법에 관한 것으로, 보다 상세하게는 쇠비름 추출물 및 피톤치드를 유효성분으로 함유하는 항균 활성이 우수한 천연 여성 청결제 및 이의 제조방법에 관한 것이다.
The present invention relates to a natural female cleanser and a method for producing the same, and more particularly, to a natural female cleanser having excellent antimicrobial activity and containing a carnauba extract and phytoncide as an active ingredient, and a method for producing the same.
여성의 질은 외음부와 자궁의 연결 통로로 여성의 몸에서 가장 습기가 많고 따뜻한 곳이다. 따라서 질염의 주원인인 세균이나 곰팡이가 서식하기 적합한 환경이므로 그로 인한 질환이 발생할 가능성이 크다. 정상적인 조건에서는 질 내부에 많은 유산균이 서식하면서 질 내부를 약산성으로 만들어 병원균이나 곰팡이가 증식하는 것을 억제하지만, 항생제 장기복용이나 피임약 장기복용, 탐폰이나 루프사용 또는 임신이나 출산, 수유, 폐경 등으로 여성 호르몬의 균형 변화 등의 이유로 질 내부의 균형이 깨어질 때 질 내에서 정상적인 조건에서는 성장이 통상적으로 억제되는 기회감염성 병원체의 증식이 일어나 질염이 발병할 수 있다. 질염은 세균성 질염(bacterial vaginosis), 칸디다성 질염(Candida vaginitis), 트리코모나스 질염(Trichomonas vaginitis), 위축성 질염(Atrophic vaginitis) 등이 보고되어 있다. 가장 흔한 질환은 세균성 질염으로, 가드네렐라 바지날리스(Gardnerella vaginalis)에 의해 발병하며, 세균성 질염과 함께 흔한 칸디다성 질염은 진균인 칸디다 알비칸스(Candida albicans)균에 의해 발병한다.The quality of the woman is the connection between the vulva and the uterus, which is the most humid and warm place in the female body. Therefore, bacteria and fungi, which are the main causes of vaginitis, are suitable for habitat, so the diseases are likely to occur. Under normal conditions, many lactic acid bacteria live in the vagina, making the inside of the vagina mildly acidic and inhibiting the growth of pathogens and molds. However, it is difficult to prevent the growth of pathogens or fungi by using long-term antibiotics, long-term use of pills, use of tampons or loops or pregnancy or childbirth, When the balance inside the vagina breaks down due to hormonal balance changes, vaginitis may occur due to the proliferation of opportunistic pathogens that normally inhibit growth under normal conditions in the vagina. Vaginitis has been reported as bacterial vaginosis, Candida vaginitis, Trichomonas vaginitis and Atrophic vaginitis. The most common disease is bacterial vaginosis, caused by Gardnerella vaginalis. Candida albicans, common with bacterial vaginosis, is caused by the fungus Candida albicans.
이와 같은 여성 질환을 예방하기 위하여 청결제(질세정제), 외음부 세정제를 사용하는 경우가 많다. 질염을 예방하기 위해 일반적으로 사용되고 있는 국부용 세정제로는 지방산류 또는 증류된 라우릴알코올(lauryl alcohol) 등을 설폰화하고 완화제, 점증제, 영양제, 기포제, 유기 살균제 등을 합성한 투명 또는 로숀 타입의 것이 출하된 바 있다. 또한 세정력을 지닌 계면 활성제 및 의약품으로서의 포비돈-요오드를 주성분으로 하는 것도 있다. 상기한 화학적 합성에 의한 소독제인 포비돈-요오드는 칸디다성 질염, 트리코모나스 질염 및 기타 질 감염증의 예방 및 치료에 효능이 있는 것으로 알려져 있으나, 요오드 등의 과민 증상이나 점막 손상에 의한 소양감, 작열감, 피부 궤양, 접촉성 피부염 등을 일으킬 우려가 있으며 질내 무기 요오드 또는 혈중 총 요오드수치가 상승하여 갑상선 기능 저하증을 유발할 수 있는 것으로 알려져 있다. 상기한 바와 같은 의약품으로서의 소독제의 사용에 의한 부작용을 해소하기 위한 종래의 기술로서는, 건강한 여성의 경우 질내 유익 미생물에 의한 젖산 분비에 의해 질 내 산도가 pH3.2로 유지되며 이러한 낮은 산도에서는 대부분의 유해균이 증식 억제 내지 사멸한다는 점에 기초하여, 젖산을 주성분으로 하며 우유에서 추출한 락토세럼(lactoserum)을 첨가한 pH3.5의 완충 용액 제제가 제안되어 있으나, 이것은 여성용 청결제라고 하기 보다는 질내 pH를 정상 상태로 유지시키는 질내 적정 산도 유지제이며, 근본적인 치료와 예방을 기대하기 힘들다. 또한 질염의 일반적인 치료제로서 Polyene계 약물에는 nyststin, amphotericinB가 있으며, Azole계 약물에는 ketoconazole, miconazole과 같은 imidazole계 약물과 itraconazole, fluconazole과 같은 triazole계 약물이 있다.In order to prevent such female diseases, a cleaning agent (vaginal cleanser) and a vulva cleanser are often used. Local cleaning agents commonly used to prevent vaginitis include transparent or rosin-type detergents which are obtained by sulfonating fatty acids or distilled lauryl alcohol and synthesizing emollients, thickeners, nutrients, foaming agents and organic disinfectants Have been shipped. In addition, there are surfactants with detergency and povidone-iodine as a medicine as a main component. It is known that povidone-iodine, which is a chemical disinfectant by chemical synthesis, is effective for the prevention and treatment of candidiasis vaginitis, trichomoniasis vaginitis and other vaginal infections. However, it is known that povidone- , Contact dermatitis, etc., and it is known that iodine or total iodine in blood may be elevated in the vagina to cause hypothyroidism. As a conventional technique for solving the side effects caused by the use of the disinfectant as a medicine as described above, the vaginal acidity is maintained at pH 3.2 by the secretion of lactic acid by vaginally beneficial microorganisms in healthy women, On the basis of the fact that the harmful bacteria are inhibited or killed, a buffer solution having pH 3.5, in which lactoserum extracted from milk and containing lactic acid as a main component is added, is proposed. However, It is difficult to expect fundamental treatment and prevention. In addition, polyene-based drugs include nyststin and amphotericinB, and azole-based drugs include imidazole-based drugs such as ketoconazole and miconazole, and triazole-based drugs such as itraconazole and fluconazole.
상기와 같은 항생제는 충분치 못한 양을 투여했을 경우에는 병균은 죽지 않고 내성으로 인하여 오히려 차후 치료에 더 큰 어려움을 낳는다. 또한 세정제로 사용되는 화학적 질 세정제는 장기간 사용시 세정효과가 저하되고 잡균은 제거되는 대신 진균이 증가하며, 악취 및 불쾌한 냄새 제거 효과가 저해되는 등 한계가 있다. 상기와 같은 많은 방법들이 개발이 되어 있더라도 재발이 잘 일어나는 문제점이 있다.
When such an antibiotic is administered in an insufficient amount, the germs do not die, resulting in a greater difficulty in the subsequent treatment because of resistance. In addition, the chemical quality detergent used as a detergent has a limitation in that the detergent is deteriorated in long-term use, fungi are removed instead of removing germs, and odor and unpleasant odor removing effect are inhibited. Even if many methods as described above are developed, there is a problem that recurrence occurs well.
한편, 질염 예방 및 치료제의 결점을 보완하고자, 생약재를 이용하여 제조된 생리대 도포용 조성물(대한민국 공개특허공보 특 2001-0014909) 및 생리대 패드(대한민국 공개특허공보 특 2002-0062474), 한천을 이용한 국부 세척용 세제(대한민국 등록특허 특 1979-0001672)가 개시되어 있으며, 여성 국부세정용 조성물과 관련하여 점막부위에 세정 제거가 용이하며 안전한 여성용 청결제 조성물 (대한민국 특허 출원 제10-2004-0072503호), 죽염 및 복합 생약 추출물을 포함하는 여성용 청결제 조성물(대한민국 특허 출원 제 10-20040085458호), 석류피 추출물을 함유한 질 세정제 조성물 및 그 제조방법(대한민국 특허 출원 제10-2004-0085204호), 질염 예방 및 치료에 유용한 유효성분의 추출방법 및 이를 이용하여 추출된 추출물을 함유하는 세정제 조성물(대한민국 공개 특허 제 10-2003-004587호), 프로폴리스 함유 여성용 청결제 조성물 및 그 제조방법(대한민국 특허 출원 제 10-1999-0037078호), 고삼, 애엽, 작약 및 홍삼을 포함하는 여성 국부세정용 한방 조성물(대한민국 특허 출원 제 10-2009-0023172호) 등이 개시되어 있다. 상술한 바와 같이 질 세정 및 이상 증상을 치료하기 위한 방법으로서 여러 가지 약물이 제시되고 있으나 사용의 부위가 외부 물질에 대한 가장 민감한 점막 부위임을 염두한 자극성이 없는 약물의 제시는 아직 미흡한 실정이다. 따라서 자극성과 부작용이 없는 천연 추출물을 이용한 조성물에 대한 지속적인 요구를 충족시키기 위한 새로운 기술의 개발이 요구되고 있다.
On the other hand, in order to complement deficiencies of the vaginitis prevention and treatment agent, a composition for applying a sanitary napkin (Korean Patent Laid-Open Publication No. 2001-0014909) and a sanitary pad (Korean Patent Publication 2002-0062474) (Korean Patent Application No. 1979-0001672) discloses a cleaning composition for women (Korean Patent Application No. 10-2004-0072503), which is easy to clean and remove at mucous membrane sites in connection with a composition for local cleansing of women, (Korean Patent Application No. 10-20040085458), a composition of a quality detergent containing ginseng extract and a method for producing the same (Korean Patent Application No. 10-2004-0085204), prevention and treatment of vaginitis A method of extracting an effective ingredient useful for treatment and a detergent composition containing the extract extracted therefrom (Korean Patent Laid-Open No. 10-20 (Korean Patent Application No. 10-1999-0037078), a herbal composition for local cleansing of women including gosams, lobes, peonies and red ginseng (Korean Patent Application No. 2003-004587), a cleaner composition for women containing propolis 10-2009-0023172). As described above, various drugs have been proposed as a method for treating vaginal cleansing and abnormal symptoms, but there is still a lack of presentation of non-irritating drugs considering that the site of use is the most sensitive mucosal site for foreign substances. Thus, there is a need to develop new technologies to meet the continuous need for compositions using natural extracts that are free of irritation and side effects.
이에 본 발명은 상기 문제점을 해결하기 위해, 인체 친화적인 천연 추출물을 이용하여, 부작용이 따르는 기존의 화학 약품과 달리, 부작용 및 자극성이 없고 질염 환자의 병변을 경감시킴으로써 증상의 예방 및 치료 효과가 우수할 뿐만 아니라, 여성용 청결제 조성물에 적용할 때, 그 제형 가공의 편리성과 적용시에 효과 저하성이 전혀 없어 다양한 형태의 제형 제조 및 이에 맞게 사용되도록 제품화하여 질염 환자가 편리하게 여러 가지 제형을 사용가능할 수 있는 조성물을 제공한다.
In order to solve the above problems, the present invention has been made to solve the above-mentioned problems, and it is an object of the present invention to provide a pharmaceutical composition for preventing and treating symptoms by preventing human adverse effects and irritation, In addition, when applied to a cleanser composition for women, there is no deterioration in the convenience of the formulation and application thereof, so that various formulations can be manufactured and manufactured so that they can be used appropriately. ≪ / RTI >
본 발명의 목적은 부작용 및 독성이 적은 천연 추출물로서 쇠비름 추출물과 편백나무에서 추출한 피톤치드을 유효성분으로 함유하는 항균 및 항진균 활성을 갖는 여성 청결제 조성물을 제공하는 것이다.
It is an object of the present invention to provide a female detergent composition having antimicrobial and antifungal activity, which contains an extract of Aspergillus oryzae and phytoncide extracted from a cottonwood as an active ingredient as a natural extract having low side effects and toxicity.
상기 목적을 달성하기 위하여, 본 발명은 쇠비름 추출물 및 피톤치드을 유효성분으로 함유하는 여성 청결제 조성물을 제공한다.In order to attain the above object, the present invention provides a female cleanser composition comprising a glycan extract and phytoncide as an active ingredient.
또한, 본 발명은 In addition,
1) 쇠비름을 세척 및 건조시킨 후, 물, 알코올 또는 알코올 수용액으로 추출한 다음, 여과하여 쇠비름 추출물을 제조하는 단계;1) washing the leggings, drying the leggings, extracting them with water, an alcohol or an aqueous alcohol solution, and then filtering them to prepare a glycyrrhiza extract;
2) 상기 단계 1)의 쇠비름 추출물과 피톤치드를 혼합하여 중화시키는 단계; 및2) neutralizing the mixture of legume extract and phytoncide in step 1); And
3) 상기 단계 2)의 중화된 혼합물을 정제수와 혼합시키는 단계를 포함하는 여성 청결제 조성물의 제조방법을 제공한다.3) mixing the neutralized mixture of step 2) with purified water.
또한, 본 발명은 쇠비름 추출물 및 피톤치드를 유효성분으로 함유하는 항균 및 항진균용 약학적 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for antibacterial and antifungal use, which contains a carnauba extract and phytoncide as an active ingredient.
아울러, 본 발명은 쇠비름 추출물 및 피톤치드를 유효성분으로 함유하는 항균 및 항진균용 의약외품 조성물을 제공한다.
In addition, the present invention provides a quasi-drug composition for antimicrobial and antifungal use, which contains a carnauba wax extract and phytoncide as an active ingredient.
본 발명은, 종래의 기술과 대비하여, 종래의 먹는 질염약의 경우 간 독성이나 소화장애, 질염 원인균에 대한 내성을 초래할 수 있고, 바르는 연고의 경우에는 피부자극으로 인하여 접촉성 피부염이 발생하는 경우가 있으나, 본 발명에 따른 쇠비름 추출물 및 편백나무에서 추출한 피톤치드의 조성물은 천연물로서 인체의 적용에 있어서 피부의 점막에 대한 자극 등과 같은 부작용 및 독성이 없어 위험부담 없이 적용가능하고, 항균활성이 매우 우수하여 칸디다성 질염과 세균성 질염의 병변을 현저히 경감시키고, 제형 가공의 편리성과 적용시의 효과 저하성이 전혀 없어 다양한 형태의 제형 제조가 가능하다.
In contrast to the prior art, the present invention is based on the discovery that conventional edible vaginitis medicines may cause liver toxicity, digestive disorders, resistance to vaginitis causing bacteria, and in case of applied ointment, contact dermatitis occurs due to skin irritation However, the composition of phytolitic extract and the phytoncide extracted from cottonwood according to the present invention is a natural product and can be applied without risk because it has no adverse effects such as irritation to the mucous membrane of the skin in the application of human body and toxicity, and has excellent antimicrobial activity , It is possible to remarkably alleviate the lesions of Candida albicans and bacterial vaginitis, and it is possible to manufacture various types of formulations because of the convenience of formulation and the deterioration of effect upon application.
이하 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명은 쇠비름 추출물 및 피톤치드을 유효성분으로 함유하는 여성 청결제 조성물을 제공한다.The present invention provides a female detergent composition comprising a glycan extract and phytoncide as an active ingredient.
여기서, 쇠비름은 쇠비름과의 1년생 잡초로서 오행초(五行草), 장명채(長命采), 마치채(馬齒菜) 등으로 불리기도 하는데, 주로 길가, 텃밭 등에서 자생하며, 줄기의 높이가 약 15~30cm 내외로 털이 없으며, 줄기는 갈적색이고 가지가 많이 갈라져서 땅 위로 비스듬히 퍼진다. 뿌리는 흰색이지만 손으로 훑으면 원줄기와 같이 붉은색으로 변한다. 잎은 마주나거나 어긋나기도 하지만 끝부분의 것은 윤생(輪生)한다. 잎 형태는 거꾸러진 달걀모양이고 끝이 둥글며 밑부분이 좁아져서 짧은 잎자루가 된다. 잎의 길이는 1.5 ~ 2.5 cm, 넓이는 0.5 ~ 1.5 cm로서 가장자리가 밋밋하다. 6 ~ 10월경에 꽃이 피는데 꽃은 노란색이며 양성으로서 가지 끝에 달리고 꽃받침은 두 개이며 타원형이다. 꽃잎은 다섯 개이며 한낮에 잠깐 꽃이 피었다가 곧 오무라든다. 7 ~ 12개의 수술과 한 개의 암술이 있고 자방(子房)은 중앙 부위에 위치해 있으며 암술대는 다섯 개다. 8월부터 개과가 여무는데 개과는 타원형이며 중앙부가 옆으로 갈라져서 긴 대가 달린 많은 종자가 나온다. 이러한 쇠비름은 양념 등으로 버무려서 식용하거나 약재로도 활용되고 있다.Here, leggings are one year old weeds of the genus Pseudomonas, and they are also called as the five legs, the long legs, and the horses, and they grow naturally on the roads and in the garden, There are no hairs in the range of 15 ~ 30cm, the stem is reddish, the branches are split a lot and spread diagonally over the ground. The roots are white, but when scratched by hand, they turn red as the main stem. Leaves are opposite to each other or alternate, but those at the end of the leaves are annihilated. The leaf form is egg-shaped, the end is round, the bottom is narrowed, and it becomes short petiole. Leaf length is 1.5 to 2.5 cm, width is 0.5 to 1.5 cm, and the edge is plain. Flowers bloom around June to October, and the flowers are yellow. They are positive and hang on the ends of the branches. There are two calyxes and ovals. There are five petals, and the flowers bloom in the middle of the day and soon it is called Oh. There are seven to twelve stamens and one pistil, and the ovaries are located in the central region, with five styles. The dogs are oval in August, but the canines are oval, and the central part is divided into sides, resulting in a large number of seeds with long stalks. These leggings are used as seasonings and edible or as medicines.
여기서, 피톤치드는 편백나무에서 추출한 물질이다. 편백나무(Chamaecyparis obtusa)는 노송나무라고도 하며, 겉씨식물 구과목 측백나무과의 상록교목으로서, 일본이 원산지이지만 개발을 통해 우리나라 남부 지방에서 조림수종으로 널리 재배되고 있는데, 편백나무 특유의 향으로 인해 탈취제, 항균제 등으로 사용되고 있다. 편백나무에서 생산되는 피톤치드는 식물의 자기방어물질로써, 병원균 및 해충, 곰팡이 등에 저항하기 위해 식물이 내뿜거나 분비하는 물질로 그 자체에 살균, 살충성분이 포함되어 있다. 피톤치드의 구성물질은 테르펜을 비롯한 페놀 화합물, 알칼로이드 성분, 글리코시드 등으로 이루어진 유기화합물이며, 항균작용, 진정작용, 탈취작용, 스트레스 해소작용 등을 하는 것으로 알려져 있다. 이러한 피톤치드는 화학합성 물질이 아닌 천연물질이고, 인간의 신체에 무리 없이 흡수되며, 인간에게 해로운 균들을 선택적으로 살균한다. 또한, 피톤치드는 항균작용, 소취작용, 진정작용 및 스트레스 해소 작용 등 수많은 기능을 하는 것으로 알려져 있다. 또한, 피톤치드는 뛰어난 살균, 항균, 세정작용으로 피부를 깨끗하게 하고 보습작용도 하며, 체내의 면역 기능을 강화한다.Here, phytoncide is a substance extracted from cottonwood. Chamaecyparis obtusa, also known as cypress tree, is an evergreen tree of the ginseng plant, a plant species, and is widely cultivated as a planting species in the southern part of Korea through development, although it is originated in Japan. , Antibacterial agents and the like. Phytoncide is a self-defense substance of plants. It is a substance that plants excrete or secretes to resist pathogens, insects and fungi, and contains sterilization and insecticides. The constituent material of phytoncide is an organic compound composed of a phenol compound such as terpene, an alkaloid component, a glycoside, etc., and is known to have antimicrobial action, sedative action, deodorizing action and stress relieving action. Such phytoncide is a natural substance, not a chemical synthetic substance, and selectively absorbs bacteria which are absorbed in human body and harmful to human being. Phytoncide is known to have many functions such as antimicrobial action, deodorizing action, sedative action and stress relieving action. In addition, phytoncide has excellent sterilization, antibacterial and cleansing action, cleansing the skin, moisturizing and enhancing the immune function in the body.
본 발명에 따른 조성물에서, 쇠비름 추출물과 피톤치드를 1 ~ 4 : 1 ~ 4 중량 비율로 혼합한 것이 바람직하고, 1 : 1 중량 비율로 혼합한 것이 더욱 바람직하다.In the composition according to the present invention, the glycyrrhiza extract and phytoncide are preferably mixed at a ratio of 1: 4: 1 to 4: 1, more preferably 1: 1.
상기 쇠비름 추출물은 쇠비름을 물, 알코올 또는 이들의 혼합물을 용매로 추출한 추출물인 것이 바람직하다. 이때, 추출방법은 냉침 추출, 온침 추출, 열 추출 또는 초음파 추출이 모두 사용가능하며, 추출온도는 5 ~ 80℃가 바람직하고 5 ~ 25℃의 저온인 것이 더욱 바람직하며, 추출시간은 50일 ~ 200일인 것이 바람직하고 100 ~ 150일인 것이 더욱 바람직하다. 이때, 제조된 추출물은 이후 여과하거나 농축 또는 건조과정을 수행하여 용매를 제거할 수 있으며, 여과,농축 및 건조를 모두 수행할 수 있으며, 상기 여과는 여과지를 이용하거나 감압여과기를 이용할 수 있으며, 상기 농축은 감압 농축기, 예를 들면 회전 증발기를 이용하여 감압농축할 수 있으며, 상기 건조는 예를 들면 동결건조법으로 수행할 수 있다.
The glycyrrhiza extract is preferably an extract obtained by extracting legumes as a solvent with water, alcohol or a mixture thereof. The extraction temperature may be 5 to 80 ° C., more preferably 5 to 25 ° C., and the extraction time may be 50 to 100 ° C., 200 days, and more preferably 100 to 150 days. The extract may be filtered, concentrated or dried to remove the solvent. Filtration, concentration and drying may all be performed. The filtration may be performed using a filter paper or a vacuum filter, The concentration can be reduced by using a reduced pressure concentrator, for example, a rotary evaporator, and the drying can be performed, for example, by the freeze drying method.
본 발명에 따른 조성물에서, 천궁 추출물, 단삼 추출물, 사상자 추출물 및 지부자 추출물로 구성된 군으로부터 선택된 어느 하나 이상을 더 포함하는 것이 바람직하다. 이때, 본 발명의 조성물에 천궁 추출물, 단삼 추출물, 사상자 추출물 및 지부자 추출물를 더 포함하는 경우, 쇠비름 추출물 1 ~ 4 : 피톤치드 1 ~ 4, 천궁 1 ~ 4, 단삼 1 ~ 4, 사상자 1 ~ 4, 및 지부자 1 ~ 4 비율로 혼합된 것이 바람직하고, 이들이 동일한 비율로 혼합되는 것이 더욱 바람직하다.In the composition according to the present invention, it is preferable that the composition further comprises at least one selected from the group consisting of citron extract, rosemary extract, caspase extract, and leaf extract. In the case where the composition of the present invention further contains the extract of Chenopodium acuminata, the extract of Chenopodium ambrosioides, the extract of caspase-3, and the extract of Quercus acutissima, the extract of Pseudomonas sativus 1 to 4: Phytoncide 1 to 4, Astragalus 1 to 4, Chenopodium 1 to 4, Caspase 1 to 4, It is preferable to mix them at a ratio of 1 to 4, and it is more preferable that they are mixed at the same ratio.
여기서, 천궁은 학명은 Cnidium officinale MAKINO으로서 높이는 30 ~ 60 ㎝이고 곧추 자라며 가지가 갈라진다. 잎은 어긋나고 2회우상복엽이며 근생엽은 엽병이 길고 경생엽(莖生葉)은 위로 올라갈수록 점차 작아지며 밑부분이 엽초(잎깍지)로 되어 원줄기를 감싸고 소엽은 난형 또는 피침형으로서 결각상(缺刻狀)의 톱니와 더불어 예리한 톱니가 있다. 꽃은 8월에 피며 가지 끝과 원줄기 끝에서 큰 산형화서가 발달한다. 어린순은 나물로 먹고 뿌리줄기는 건조시켜 약재로 이용한다. 성분은 방향성 정유를 다량 함유하고 있어서 냄새가 좋다. 동물을 통한 약리적 작용실험에서 중추신경계통에 작용하여 진정효과가 있음을 확인하였으며, 약하지만 지속적인 혈압강하작용도 확인되었다. 평활근에 대한 실험에서는 자궁의 수축력을 증대시켜 주고 또 살균작용이 있어서 대장균, 이질균, 녹농균 및 피부진균의 발육을 억제시키는 효과가 나타났다.Here, the scientific name of Cnidium officinale MAKINO is 30 ~ 60 ㎝ in height and grows straight and branches are divided. Leaves are alternate phyllotaxis with two alternate phyllotaxis. Leaves are long and petiole is long. Leaves are gradually smaller as they go up. Leaves are leaf sheath and wrap around main stem. Leaves are ovate or lanceolate. There are sharp cogs along with cogs. Flowers bloom in August, and large phloem episodes develop at the ends of the branches and the main stem. The young seeds eat as herbs and the rootstock is dried and used as medicinal materials. The ingredient contains a large amount of aromatic essential oil, so it has a good smell. In pharmacological experiments with animals, it was found to have a sedative effect on the central nervous system, and a weak but sustained hypotensive effect was also confirmed. In the experiment on smooth muscle, the contraction power of the uterus was increased, and the sterilization was also effective in suppressing the development of Escherichia coli, Dysentery, Pseudomonas aeruginosa, and Skin fungi.
여기서, 단삼(Salvia Miltiorrhiza Root)은 단삼(Salvia miltiorrhiza Bunge (꿀풀과 Labiatae))의 뿌리이며, 근경이 짧고 거칠며 정단에는 보통 줄기가 붙었던 자국이 남아 있다. 단삼의 물 추출액은 여러가지 피부진균에 억제 작용이 있으며 동의치료에서 강장약, 통경약, 아픔멎이약, 항염증약, 피멎이약으로 월경불순, 배아픔, 폐경, 산후 배아픔, 류머트즘에 쓴다. 주로 부인병 치료약으로 뿌리만을 가루내어 먹어도 사물탕과 같은 치료 효과가 있다.Here, Salvia Miltiorrhiza Root is the root of Dansam (Salvia miltiorrhiza Bunge (Lamiaceae and Labiatae)), which has a short rhizome and rough edges, and usually has stalks on the top. The water extract of Dansam has an inhibitory effect on various skin fungi and it is used for the treatment of bronchial hyperplasia, menopause, postpartum embarrassment, rheumatism with antibiotics, bronchodilator, pain medication, antiinflammatory drug, . It is mainly treated with gynecological diseases, but it has the same therapeutic effect as the soup even if it takes out only the root.
여기서, 사상자(Cnidi Fructus)는 벌사상자(Cnidium monieri(L). Cuss) 또는 사상자(Torilis japonica Decandolle)의 과실이다. 본초강목에는 여성의 생식기가 붓고 아픈 것, 생식기 주변이 습하고 가려운 증상을 치료한다고 기록되어있으며, 음부 소양감, 피부소양증, 여성의 대하에 효과가 있다.Here, Cnidi Fructus is the fault of Cnidium monieri (L. Cuss) or Casualties (Torilis japonica Decandolle). It is said that the genital hernia of the female is swollen and sick, the genital area is treated to treat humid and itchy symptoms, and it is effective for the vaginal cannibalism, skin pruritus, and females.
여기서, 지부자(Kochiae fructus)는 댑싸리(Kochia scoparia Schrader)의 성숙한 열매이다. 지부자는 임질과 부인들의 대하 등을 다스리고 습열로 인한 피부 질환에도 응용되는데, 소양증이나 습진 등을 다스린다.
Here, Kochiae fructus is a mature fruit of the Kochia scoparia Schrader. Branch owners control gonorrhea and wives and their skin and are also applied to skin diseases caused by moist heat, such as pruritus and eczema.
본 발명에 따른 조성물은 그 사용에 특별히 제한되지 않으며, 예를 들면 질염 예방 또는 치료를 위한 여성용 청결제 조성물 등에 사용될 수 있다. 또한, 상기 여성용 청결제 조성물은 세정제용, 약제용, 화장료용, 물티슈용 등으로 사용될 수 있다.The composition according to the present invention is not particularly limited in its use, and can be used, for example, in a female detergent composition for prevention or treatment of vaginitis. In addition, the above-described cleaner composition for women can be used for a detergent, a medicine, a cosmetic, a wet tissue, or the like.
상기 세정제용은 스프레이형, 액상형, 젤형, 분말, 고형의 비누, 폼타입 등으로 제형화 된 것일 수 있고, 상기 화장료용은 임의로 제형을 선택할 수 있되 종래의 일반적 화장료 제형인 로션, 화장수, 크림, 에센스, 에어로졸, 파우더, 오일 또는 미스트 등으로 제조된 것일 수 있으며, 상기 약제용은 경구투여를 위한 고형제제로서 정제, 환제, 산제, 과립제, 캡슐제 등으로 제형화된 것일 수 있고, 비경구투여를 위한 형태로서 크림, 연고, 로션, 드레싱용액, 분무제, 기타 도포제 등으로 제형화된 것일 수 있다.The detergent may be in the form of a spray, a liquid, a gel, a powder, a solid soap, a foam, and the like. The cosmetic may optionally include a lotion, lotion, cream, The pharmaceutical preparation may be a solid preparation for oral administration, which is formulated into tablets, pills, powders, granules, capsules and the like, and may be parenterally administered A cream, an ointment, a lotion, a dressing solution, a spray, and other coating agents.
본 발명에 따른 조성물은 여성용 청결제 조성물에 사용되는 경우 여성용 청결제 조성물 전체 중량에 대하여 10중량% 내지 100중량% 포함되는 것이 바람직하다. The composition according to the present invention is preferably contained in an amount of 10% by weight to 100% by weight based on the total weight of the female cleaner composition when it is used in a female cleaner composition.
본 발명에 있어서, 화장료용 또는 피부 외용제용 여성 청결제 조성물은 본 발명에 따른 조성물 외에도 필요에 따라 효과를 저하시키지 않는 범위 내에서 피부 외용제에 일반적으로 사용가능한 각종 성분, 예를 들면 수용성 성분, 분말성분, 유분, 계면활성제, 보습제, 점도 조절제, 방부제, 산화방지제, 향료, 색소 등을 배합하는 것이 가능하다. 그리고, 화장료용 또는 피부 외용제용 여성 청결제 조성물은 유분, 물, 계면활성제, 보습제, 점증제, 킬레이트제, 색소, 방부제, 및 향료로 이루어지는 군으로부터 1 종 이상 선택되는 첨가제를 추가로 포함할 수 있다.
In the present invention, in addition to the composition according to the present invention, in addition to the composition according to the present invention, a female cleansing composition for a cosmetic or external preparation for skin may contain various components generally usable in external preparations for skin such as a water- , Oil, surfactant, moisturizing agent, viscosity controlling agent, preservative, antioxidant, fragrance, pigment and the like. The female cleansing composition for cosmetic or dermatological use may further comprise at least one additive selected from the group consisting of oil, water, surfactant, moisturizing agent, thickening agent, chelating agent, coloring agent, preservative and fragrance .
또한, 본 발명은 In addition,
1) 쇠비름을 세척 및 건조시킨 후, 물, 알코올 또는 알코올 수용액으로 추출한 다음, 여과하여 쇠비름 추출물을 제조하는 단계;1) washing the leggings, drying the leggings, extracting them with water, an alcohol or an aqueous alcohol solution, and then filtering them to prepare a glycyrrhiza extract;
2) 상기 단계 1)의 쇠비름 추출물과 피톤치드를 혼합하여 중화시키는 단계; 및2) neutralizing the mixture of legume extract and phytoncide in step 1); And
3) 상기 단계 2)의 중화된 혼합물을 정제수와 혼합시키는 단계를 포함하는 여성 청결제 조성물의 제조방법을 제공한다.3) mixing the neutralized mixture of step 2) with purified water.
상기 제조방법에 있어서, 상기 단계 1)의 건조는 5 ~ 25℃에서 20 ~ 40시간 노출시켜 수분을 증발시키는 것이 바람직하고, 5 ~ 15℃에서 24 ~ 30시간 노출시켜 수분을 증발시키는 것이 더욱 바람직하다.In the above production process, it is preferable that the drying of step 1) is carried out at 5 to 25 ° C for 20 to 40 hours to evaporate moisture, and more preferably to evaporate moisture at 5 to 15 ° C for 24 to 30 hours Do.
상기 제조방법에 있어서, 단계 1)의 추출은 건조된 쇠비름을 물, 알코올 또는 알코올 수용액과 혼합한 후 5 ~ 25℃에서 50일 ~ 200일 동안 담가 놓아 추출하는 것이 바람직하고, 5 ~ 15℃에서 100일 ~ 150일 동안 담가 놓아 추출하는 것이 더욱 바람직하다.In the above production method, the extraction of step 1) is preferably carried out by mixing the dried glycyrrhiza with water, an alcohol or an aqueous alcohol solution, and then extracting the mixture at 5 to 25 ° C for 50 to 200 days, It is more preferable to immerse in 100 to 150 days for extraction.
상기 제조방법에 있어서, 단계 2)의 혼합은 쇠비름 추출물과 피톤치드는 1 ~ 4 : 1 ~ 4 중량 비율로 혼합한 것이 바람직하고, 1 : 1 중량 비율로 혼합한 것이 더욱 바람직하다.In the above preparation method, the mixture of step 2) is preferably mixed with carnauba wax extract and phytoncide at a ratio of 1: 4: 1 to 4: 1, and more preferably 1: 1.
상기 제조방법에 있어서, 단계 2)에서 천궁 추출물, 단삼 추출물, 사상자 추출물 및 지부자 추출물로 구성된 군으로부터 선택된 어느 하나 이상을 더 혼합할 수 있다. 이떼, 혼합 비율은 각각 1 ~ 4 중량 비율로 혼합한 것이 바람직하다.In the above-mentioned preparation method, at least one selected from the group consisting of cucurbitaceae extract, ginsenosides extract, caspase extract, and leaf extract can be further mixed in step 2). It is preferable that the mixing ratio is 1 to 4 weight ratio.
상기 제조방법에 있어서, 단계 3)의 정제수는 70 ~ 80℃인 것이 바람직하다.
In the above production method, the purified water in step 3) is preferably 70 to 80 ° C.
또한, 본 발명은 쇠비름 추출물 및 피톤치드을 유효성분으로 함유하는 항균 및 항진균용 약학적 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for antibacterial and antifungal use, which contains a carnauba wax extract and phytoncide as an active ingredient.
아울러, 본 발명은 쇠비름 추출물 및 피톤치드을 유효성분으로 함유하는 항균 및 항진균용 의약외품 조성물을 제공한다.In addition, the present invention provides a quasi-drug composition for antibacterial and antifungal use, which contains a carnauba wax extract and phytoncide as an active ingredient.
본 발명에 따른 항균 및 항진균용 조성물에서, 천궁 추출물, 단삼 추출물, 사상자 추출물 및 지부자 추출물로 구성된 군으로부터 선택된 어느 하나 이상을 더 포함하는 것이 바람직하다.In the antimicrobial and antifungal composition according to the present invention, it is preferable that the composition further comprises at least one selected from the group consisting of citron extract, ginseng extract, caspase extract,
본 발명에 있어서, 항균 및 항진균용 조성물이란 본 발명에 따른 쇠비름 추출과 피톤치드의 혼합물이 조성물 전체 중량에 대하여 10 ~ 100중량%로 포함된 조성물로서, 질염의 원인이 되는 진균류인 칸디다 알비칸스(Candida albicans)와 일반세균인 가드네렐라 바지날리스(Gardnerella Vaginalis)에 항균 활성이 우수한 조성물을 의미한다.In the present invention, the composition for antibacterial and antifungal use according to the present invention is a composition comprising 10% to 100% by weight of a mixture of Peppermint Extract and Phytoncide according to the total weight of the composition, wherein Candida albicans (Candida albicans) and a general bacterium (Gardnerella vaginalis).
본 발명에 있어서, 항균 및 항진균용 조성물은 항균 및 항진균 기능을 포함하는 화장품, 피부 세정제, 소독제 또는 물티슈 등으로 사용될 수 있다.
In the present invention, the composition for antibacterial and antifungal use may be used as a cosmetic, a skin cleanser, a disinfectant, a wet tissue or the like containing antibacterial and antifungal functions.
이하, 실시예, 실험예 및 제조예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예, 실험예 및 제조예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예, 실험예 및 제조예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail by way of Examples, Experimental Examples and Preparation Examples. It is to be understood that both the present invention and the following examples are for illustrative purposes only and that the scope of the present invention is not limited by these examples, And will be apparent to those skilled in the art.
<< 실시예Example 1> 쇠비름 추출물 및 피톤치드를 함유하는 조성물의 제조 1 > Preparation of a composition containing glycyrrhiza extract and phytoncide
쇠비름을 채취한 후 깨끗히 씻은 후 저온(10℃)에 24시간 노출시켜 수분을 증발시켰다. 그런 다음, 건조된 쇠비름과 알코올을 혼합하여 저온(10℃)에서 100일 정도 담가놓은 후 여과지를 이용하여 여과시켰다. 그런 다음, 편백나무에서 추출한 피톤치드와 쇠비름 추출물을 각각 100 g씩 혼합하여 중화시켰다. 그런 다음, 70 ~ 80℃로 가열시킨 정제수와 혼합시켜 다시한번 활성화시켜 중수 상태로 만들었다.
After picking the leggings, they were cleaned and then exposed to low temperature (10 ° C) for 24 hours to evaporate water. Then, dried pepper and alcohol were mixed and allowed to stand at low temperature (10 ° C) for about 100 days and then filtered using a filter paper. Then, 100 grams of phytoncide extracted from cottonwood and pepper extract were neutralized by mixing. Then, it was mixed with purified water heated to 70 to 80 ° C and activated once more to make it into a heavy water state.
<< 실험예Experimental Example 1> 디스크 확산법을 이용한 항균 활성 측정 1> Antimicrobial activity measurement using disk diffusion method
상기 <실시예 1>에서 제조한 조성물의 항균활성을 확인하기 위하여 디스크 확산법(Disc-diffusion method)을 이용하였다.In order to confirm the antibacterial activity of the composition prepared in Example 1, the disc diffusion method was used.
<1-1> <1-1> 칸디다알비칸스에Candida albicans 대한 항균력 평가 Evaluation of antibacterial activity against
전 배양된 칸디다 알비칸스 (Candida albicans)를 디스크 확산법 측정용 평판배지(Sabouraud Dextrose Agar.Difco.USA)에 100 ㎕씩 분주하여 도말한 후, 추출물을 멸균된 페이퍼 디스크에 5 mg/disc의 농도로 시료를 점적한 후 배지 위에 올려놓았다. 이에 대한 대조군으로 항진균제인 이트라코나졸(Itraconazol)을 페이퍼디스크에 100 ㎍/disk의 농도로 시료를 점적한 후 배지 위에 올려놓았다. 이 평판배지를 28℃에서 48시간 동안 배양한 후 생육저지환(Clean Zone)의 크기를 측정하였다. 그 결과를 하기 표 1에 나타내었다. 하기 표 1에서 보는 바와 같이 본 발명의 조성물이 대조군인 이트라코나졸에 비해 강한 생육저지효과를 나타내었다.100 μl of pre-cultured Candida albicans (Sabouraud Dextrose Agar.Difco.USA) was plated on a disk medium for determination of disk diffusion method, and the extract was applied to a sterilized paper disk at a concentration of 5 mg / disc After the sample was dropped, it was placed on the medium. As a control, itraconazole, an antifungal agent, was placed on a paper disk at a concentration of 100 μg / disk. After the plate medium was incubated at 28 ° C for 48 hours, the size of the growth zone (Clean Zone) was measured. The results are shown in Table 1 below. As shown in the following Table 1, the composition of the present invention showed strong growth inhibition effect compared to itraconazole, which is a control group.
<1-2> <1-2> 가드네렐라Guard nerella 바지날리스에In pants naris 대한 항균력 평가 Evaluation of antibacterial activity against
전 배양된 가드네렐라 바지날리스(Gardnerella vaginalis)를 디스크 확산법 측정용 평판배지(Reinforced clostridial medium. Difco.USA)에 100 ㎕씩 분주하여 도말한 후, 추출물을 멸균된 페이퍼 디스크에 5 mg/disc의 농도로 시료를 점적한 후 배지 위에 올려놓았다. 이에 대한 대조군으로 항생제인 앰피실린(Ampicillin) 을 페이퍼디스크에 10 ㎍/disk의 농도로 시료를 점적한 후 배지 위에 올려놓았다. 이 평판 배지를 37℃에서 48시간 동안 배양한 후 생육저지환(Clean Zone)의 크기를 측정하였다. 그 결과를 하기 표 1에 나타내었다. 하기 표 1에 서 보는 바와 같이 본 발명의 항균제 조성물이 강한 생육저지효과를 나타내었다. 100 μl of pre-cultured Gardnerella vaginalis was dispensed into a Reinforced clostridial medium (Difco.USA) for determination of disk diffusion method, and the extract was applied to a sterilized paper disk at 5 mg / disc And then placed on the culture medium. As a control, Ampicillin, an antibiotic, was placed on a paper disk at a concentration of 10 μg / disk. After culturing the plate medium at 37 ° C for 48 hours, the size of the growth zone (Clean Zone) was measured. The results are shown in Table 1 below. As shown in Table 1, the antimicrobial composition of the present invention showed a strong growth inhibition effect.
<< 실험예Experimental Example 2> 액체 배지 감수성 실험을 이용한 최소저지 농도( 2> Minimum inhibitory concentration using liquid medium susceptibility test MICMIC )의 측정)
상기 <실시예 1>에서 제조한 조성물의 항균활성을 확인하기 위하여 액체배지감수성실험(Broth Microdilution Susceptibility Tests)법을 이용하여 항균활성 및 미생물을 50% 억제하는데 필요한 농도인 IC50(half maximal Inhibitory Concentration) 값을 측정하였다.In order to confirm the antimicrobial activity of the composition prepared in Example 1, the antimicrobial activity and IC 50 (half maximal inhibitory concentration) required for 50% inhibition of microorganisms were measured using a Broth Microdilution Susceptibility Test ) Were measured.
<2-1> 칸디다 <2-1> Candida 알비칸스에Albikanse 대한 항균력 평가 Evaluation of antibacterial activity against
칸디다 알비칸스의 세포수를 2×105 cells/ml이 되도록 Sabouraud Dextrose 배지로 희석한 후 96-well에 serial dilution 방법에 의해 시료를 농도별 처리를 하였다. 그 후, 28℃에서 24 시간 배양하고 Microplate reader(BIO-RAD)를 사용하여 570 nm 파장에서 그 흡광도를 측정하여 IC50값을 결정하였고, 그 결과를 하기 표 2에 나타내었다.The cell number of Candida albicans was diluted with Sabouraud Dextrose medium to 2 × 10 5 cells / ml and treated with serial dilution method in 96-well. After incubation at 28 ° C for 24 hours, the absorbance was measured at a wavelength of 570 nm using a microplate reader (BIO-RAD) to determine IC 50 values. The results are shown in Table 2 below.
<2-2> <2-2> 가드네렐라Guard nerella 바지날리스에In pants naris 대한 항균력 평가 Evaluation of antibacterial activity against
가드네렐라 바지날리스의 세포수를 2×105 cells/ml이 되도록 Sabouraud Dextrose 배지로 희석한 후 96-well에 serial dilution 방법에 의해 시료를 농도별 처리를 하였다. 그 후, 37℃에서 24 시간 배양하고 Microplate reader(BIO-RAD)를 사용하여 570 nm 파장에서 그 흡광도를 측정하여 IC50값을 결정하였고, 그 결과를 하기 표 2에 나타내었다.The cells were diluted with Sabouraud Dextrose medium to a cell density of 2 × 10 5 cells / ml and treated with serial dilution in 96-wells. After incubation at 37 ° C for 24 hours, the absorbance was measured at a wavelength of 570 nm using a microplate reader (BIO-RAD) to determine IC 50 values. The results are shown in Table 2 below.
<< 실험예Experimental Example 3> 미생물에 대한 영향 측정 3> Measurement of effect on microorganisms
상기 <실시예 1>에서 제조한 조성물이 락토바실러스 애시도필러스(Lactobacillus acidophilus)와 칸디다 알비칸스(Candida albicans), 가드네렐라 바지날리스(Gardnerella vaginalis)에 미치는 영향을 알아보기 위하여 시험을 실시하였다.Tests were conducted to examine the effect of the composition prepared in Example 1 on Lactobacillus acidophilus, Candida albicans and Gardnerella vaginalis. Respectively.
상기 <실험예 2>와 같은 방법으로 시행하였다. 본 방법은 배지 내의 탁도증가 여부를 통하여 미생물 증식여부를 확인할 수 있는데 이를 통하여 본 발명의 조성물에 대한 미생물의 생존율을 구할 수 있었다. 그 결과를 표 3에 나타내었다. 이 결과로 보아, 본 발명의 조성물은 락토바실러스 애시도필러스에 대해 영향을 크게 미치지 않지만, 칸디다 알비칸스와 가드네렐라 바지날리스의 생장을 저해하는 것을 알 수 있었다.The same procedure as in <Experiment 2> was conducted. The present method can confirm whether the microorganism is proliferated or not through the increase of the turbidity in the medium. Thus, the survival rate of the microorganism to the composition of the present invention can be obtained. The results are shown in Table 3. As a result, it was found that the composition of the present invention had no significant effect on Lactobacillus ashidophilus but inhibited the growth of Candida albicans and Gardnerella vaginalis.
<< 제조예Manufacturing example 1> 에어로졸 스프레이 제형의 여성용 1> For women in aerosol spray formulations 청결제Cleaner 조성물의 제조 Preparation of composition
본 발명의 조성물을 포함하여 질염의 예방 또는 치료를 위한 여성용 청결제 조성물을 에어로졸 스프레이 제형으로 제조하기 위해 아래의 성분에 의해 에어로졸 스프레이를 제조하였다.Aerosol sprays were prepared by the following ingredients to prepare a female cleanser composition for the prevention or treatment of vaginitis, including the composition of the present invention, in an aerosol spray formulation.
<배합 성분 함량 (중량%)><Ingredient Content (wt%)>
본 발명에 따른 조성물 20%The composition of the present invention 20%
계면활성제 0.15%Surfactant 0.15%
알칼리금속벤조에이트 0.015%Alkali metal benzoate 0.015%
정제수 잔량Purified water balance
합 계 100%
Total 100%
<< 제조예Manufacturing example 2> 2> 젤형Gel type 제형(크림)의 여성용 Formulations (cream) for women 청결제Cleaner 조성물의 제조 Preparation of composition
본 발명의 조성물을 포함하여 질염의 치료 및 예방을 위한 여성용 청결제 조성물을 제조하기 위해 아래의 성분에 의해 크림을 제조하였다.Creams were prepared with the following ingredients to prepare a female cleanser composition for the treatment and prevention of vaginitis, including the composition of the present invention.
<배합 성분 함량 (중량%)><Ingredient Content (wt%)>
본 발명에 따른 조성물 20%The composition of the present invention 20%
디메치콘코폴리올 10.0%Dimethicone copolyol 10.0%
사이클로메치콘 10.0%Cyclomethicone 10.0%
우레아 20.0%Urea 20.0%
글리세린 20.0%Glycerin 20.0%
트리에탄올아민 0.02%Triethanolamine 0.02%
방부제 1.0%Preservatives 1.0%
정제수 잔량Purified water balance
합 계 100%
Total 100%
<< 제조예Manufacturing example 3> 액상형 제형(물티슈)의 여성용 3> For women of liquid type formulation (wet tissue) 청결제Cleaner 조성물의 제조 Preparation of composition
본 발명의 조성물을 포함하여 질염의 치료 및 예방을 위한 여성용 청결제 조성물을 제조하기 위해 아래의 성분에 의해 액상형의 조성물을 제조하였다.A liquid composition was prepared by the following components to prepare a female cleanser composition for the treatment and prevention of vaginitis, including the composition of the present invention.
<배합 성분 함량 (중량%)><Ingredient Content (wt%)>
본 발명에 따른 조성물 20%The composition of the present invention 20%
소듐라우릴설페이트 2.0%Sodium lauryl sulfate 2.0%
우레아 1.0%Urea 1.0%
L-멘톨 0.5%L-menthol 0.5%
폴리옥시에칠렌노닐페닐에텔 0.8%Polyoxyethylene nonylphenyl ether 0.8%
에탄올 15%Ethanol 15%
EDTA 0.05%EDTA 0.05%
방부제 1 %Preservatives 1%
정제수 잔량Purified water balance
합 계 100%
Total 100%
상기와 같은 액상형 조성물을 제조하여 물티슈용 원단(부직포)에 도포하였다.
The above liquid composition was prepared and applied to a fabric (non-woven fabric) for a wet tissue.
이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 균등범위 내로서 이용가능한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, And falls within the scope of the present invention.
본 발명에 따른 조성물은 여성 청결제로서 화장품, 약품, 세정제 및 물티슈 등 다양한 제형의 제품화가 가능하다.
The composition according to the present invention can be commercialized into various formulations such as cosmetics, medicines, cleaning agents and wet tissues as a female cleanser.
Claims (15)
A female cleansing composition comprising pepper extract and phytoncide as an active ingredient.
The female detergent composition according to claim 1, wherein the sorghum extract and phytoncide are mixed in a weight ratio of 1: 4: 1 to 4: 1.
The female detergent composition according to claim 1, wherein the sorghum extract is extracted with water, alcohol, or a mixture thereof.
2. The method of claim 1, wherein the phytoncide is extracted from cottonwood.
The female detergent composition according to claim 1, further comprising at least one member selected from the group consisting of Astragalus sinensis extract, Panax ginseng extract, Caspase extract and Leaf extract.
6. The female detergent composition according to claim 5, wherein the female cleansing composition is mixed at a ratio of Peppermint Extract 1 to 4: Phytoncide 1 to 4, Peppermint 1 to 4, Peppermint 1 to 4, Casualties 1 to 4, and Pepper 1 to 4.
6. The composition of claim 1 or 5, wherein the composition is a detergent, a cosmetic, or a wet tissue formulation.
2) 상기 단계 1)의 쇠비름 추출물과 피톤치드를 혼합하여 중화시키는 단계; 및
3) 상기 단계 2)의 중화된 혼합물을 정제수와 혼합시키는 단계를 포함하는 여성 청결제 조성물의 제조방법.
1) washing the leggings, drying the leggings, extracting them with water, an alcohol or an aqueous alcohol solution, and then filtering them to prepare a glycyrrhiza extract;
2) neutralizing the mixture of legume extract and phytoncide in step 1); And
3) mixing the neutralized mixture of step 2) with purified water.
The method for preparing a female detergent composition according to claim 8, wherein the drying of step 1) is performed at 5 to 25 ° C for 20 to 40 hours to evaporate moisture.
[9] The method according to claim 8, wherein the extraction of step 1) comprises mixing the dried gazebo with an aqueous solution of water, alcohol or alcohol, and then immersing the mixture at 5-25 ° C. for 50 days to 200 days .
[9] The method of claim 8, wherein the mixture of step 2) is mixed at a ratio of 1: 4: 1 to 4: 1 to 4: 1 to 4: 1.
The method for preparing a female detergent composition according to claim 8, wherein the step (2) further comprises mixing at least one selected from the group consisting of citron extract, ginsenosides extract, caspase extract, and extracts.
The method of claim 8, wherein the purified water in step 3) is 70 to 80 ° C.
The present invention relates to a pharmaceutical composition for antifungal and antifungal use, which contains a carnauba wax extract and phytoncide as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140098338A KR20160015718A (en) | 2014-07-31 | 2014-07-31 | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140098338A KR20160015718A (en) | 2014-07-31 | 2014-07-31 | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160015718A true KR20160015718A (en) | 2016-02-15 |
Family
ID=55356611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140098338A Ceased KR20160015718A (en) | 2014-07-31 | 2014-07-31 | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160015718A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108186959A (en) * | 2018-03-26 | 2018-06-22 | 成都中医药大学 | A kind of pharmaceutical composition with antibacterial anti-inflammatory, desinsection itching-relieving action and preparation method thereof |
KR20180115169A (en) | 2017-04-12 | 2018-10-22 | 주식회사 지엘컴퍼니 | Cleansing composition comprising natural raw material extract and wet tissue comprising the same |
KR102103021B1 (en) * | 2019-06-19 | 2020-04-22 | 김영자 | Antiatopyic and antivaginitis tissues containing retinispora extracts and a process for the preparation thereof |
KR20200095677A (en) | 2019-02-01 | 2020-08-11 | 진태원 | Xylitol-based parenteral compositions for effective prevention of inflammation and treatment and deodorization of female vagina |
KR20200119149A (en) | 2019-04-09 | 2020-10-19 | 진태원 | Effervescent feminine cleanser with various functions |
KR20210129536A (en) * | 2020-04-20 | 2021-10-28 | 나정식 | Manufacturing method for colloidal silver ion composition comprising phytoncide oil and colloidal silver ion composition manufactured using the same |
KR102516049B1 (en) * | 2022-11-23 | 2023-03-31 | 주식회사 프리벤티스트 | Vulvar cleaning composition that targets vaginitis bacteria |
KR20240163287A (en) | 2023-05-10 | 2024-11-19 | 인하대학교 산학협력단 | Effervescent feminine cleanser and composition thereof |
-
2014
- 2014-07-31 KR KR1020140098338A patent/KR20160015718A/en not_active Ceased
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180115169A (en) | 2017-04-12 | 2018-10-22 | 주식회사 지엘컴퍼니 | Cleansing composition comprising natural raw material extract and wet tissue comprising the same |
CN108186959A (en) * | 2018-03-26 | 2018-06-22 | 成都中医药大学 | A kind of pharmaceutical composition with antibacterial anti-inflammatory, desinsection itching-relieving action and preparation method thereof |
KR20200095677A (en) | 2019-02-01 | 2020-08-11 | 진태원 | Xylitol-based parenteral compositions for effective prevention of inflammation and treatment and deodorization of female vagina |
KR20200119149A (en) | 2019-04-09 | 2020-10-19 | 진태원 | Effervescent feminine cleanser with various functions |
KR102103021B1 (en) * | 2019-06-19 | 2020-04-22 | 김영자 | Antiatopyic and antivaginitis tissues containing retinispora extracts and a process for the preparation thereof |
WO2020256288A1 (en) * | 2019-06-19 | 2020-12-24 | 김영자 | Anti-atopy and anti-vaginitis tissue containing cypress extract and preparation method thereof |
KR20210129536A (en) * | 2020-04-20 | 2021-10-28 | 나정식 | Manufacturing method for colloidal silver ion composition comprising phytoncide oil and colloidal silver ion composition manufactured using the same |
KR102516049B1 (en) * | 2022-11-23 | 2023-03-31 | 주식회사 프리벤티스트 | Vulvar cleaning composition that targets vaginitis bacteria |
KR20240163287A (en) | 2023-05-10 | 2024-11-19 | 인하대학교 산학협력단 | Effervescent feminine cleanser and composition thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101345709B1 (en) | Antibacterial and antifungal composition and Ladies genital area cleanser composition comprising antibacterial and antifungal composition for preventing and treating vaginitis | |
KR20160015718A (en) | Feminine cleanser composition comprising Portulaca oleracea extract and Phytoncide | |
KR102133101B1 (en) | A Feminine cleanser composition comprising imperata cylindrica leaf and artemisia princeps | |
KR101870780B1 (en) | A feminine cleanser composition comprising roes damascena flower oil and propolis complex extracts | |
KR102518446B1 (en) | Natural Ingredient-Based Men's Cleaner | |
KR101651530B1 (en) | Cleanser for women's vagina using herb extract and method for manufacturing the same | |
KR102103021B1 (en) | Antiatopyic and antivaginitis tissues containing retinispora extracts and a process for the preparation thereof | |
KR101936835B1 (en) | Feminine cleanser composition comprising potato or potato pulp extract | |
KR102069297B1 (en) | Female clenaser composition | |
CN112048402B (en) | A kind of underwear soap with antibacterial, stain removal and peculiar smell and preparation method thereof | |
KR102373422B1 (en) | Composition for vaginal cleaning including functional peptides | |
KR102148808B1 (en) | Feminine Cleanser Composition Comprising Natural Antimicrobial Agents | |
KR101598083B1 (en) | An antifungal composition comprising an natural fermentation material | |
CN101904808A (en) | Ingredients that relieve skin inflammation and irritation | |
Wijayawardhana et al. | Antimicrobial activity of a combination of three natural plant extracts and development of a herbal soap. | |
KR101917644B1 (en) | Feminine cleanser composition comprising fenugreek extract | |
KR102413425B1 (en) | Feminine cleanser composition comprising beta glucan and vacuum filling ampoule comprising the same | |
KR101637194B1 (en) | Make-up soap composition containing medicinal herbs extract, amino acid complex and manufacturing method thereof | |
KR102227533B1 (en) | Shampoo compound using oriental medicine and its manufacturing methods | |
CN106344453A (en) | Novel acne cream and preparation method thereof | |
KR102292487B1 (en) | Composition for feminine hygiene care containing Copaiba resin extract | |
KR102224920B1 (en) | Cleansing composition for women's vagina comprising natural | |
KR20010025970A (en) | Propolis containing cleansing composition for ladies and process for preparing the same | |
KR20240117720A (en) | Composition for feminine cleanser containing natural extract as an active ingredient | |
KR20190123611A (en) | Anti-bacterial and anti-fungal natural product composition comprising propolis and kiwi extract and Ladies genital area cleanser composition manufactured using the anti-bacterial and anti-fungal natural product composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20140731 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20151116 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20160519 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20151116 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |